Prophase Labs Stock In The News
| PRPH Stock | USD 0.39 0.04 9.30% |
Our overall analysis of ProPhase Labs' news coverage and content from conventional and social sources shows investors' bearish mood towards ProPhase Labs. The specific impact of ProPhase Labs news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of ProPhase Labs' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using ProPhase Labs headlines in addition to utilizing other, more conventional financial analysis modules. Check out ProPhase Labs Backtesting and ProPhase Labs Hype Analysis. For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.
ProPhase |
ProPhase Labs Today Top News and Investor Outlook
ProPhase Labs Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide ProPhase and other traded companies coverage with news coverage. We help investors stay connected with ProPhase headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on ProPhase Stock performance. Please note that trading solely based on the ProPhase Labs hype is not for everyone as timely availability and quick action are needed to avoid losses.
ProPhase Labs stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the ProPhase earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about ProPhase Labs that are available to investors today. That information is available publicly through ProPhase media outlets and privately through word of mouth or via ProPhase internal channels. However, regardless of the origin, that massive amount of ProPhase data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ProPhase Labs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ProPhase Labs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ProPhase Labs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ProPhase Labs alpha.
ProPhase Largest EPS Surprises
Earnings surprises can significantly impact ProPhase Labs' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2004-10-28 | 2004-09-30 | 0.02 | 0.03 | 0.01 | 50 | ||
1997-08-13 | 1997-06-30 | 0.08 | 0.07 | -0.01 | 12 | ||
2010-11-10 | 2010-09-30 | 0.09 | 0.06 | -0.03 | 33 | ||
2000-10-26 | 2000-09-30 | -0.02 | 0.01 | 0.03 | 150 | ||
1998-10-30 | 1998-09-30 | 0.23 | 0.2 | -0.03 | 13 | ||
1998-07-31 | 1998-06-30 | -0.04 | 1.0E-4 | 0.0401 | 100 |
ProPhase Labs Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to ProPhase Labs Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
12th of March 2025
ProPhase Labs to Release Quarterly Earnings on Thursday at thelincolnianonline.com
5th of March 2025
Bears are Losing Control Over ProPhase Labs , Heres Why Its a Buy Now at zacks.com
28th of February 2025
ProPhase Labs Research Coverage Started at StockNews.com at thelincolnianonline.com
25th of February 2025
ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastruct... at finance.yahoo.com
20th of February 2025
ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over 5... at finance.yahoo.com
18th of February 2025
ProPhase Labs hires former Barstool Sports COO Stuart Hollenshead, plans cost-cutting meas... at seekingalpha.com
14th of February 2025
Acquisition by Gleckel Louis Md of 100000 shares of ProPhase Labs at 0.6 subject to Rule 1... at news.google.com
4th of February 2025
ProPhase Labs, Inc. Short Interest Up 19.1 percent in January at thelincolnianonline.com
31st of January 2025
Acquisition by Gleckel Louis Md of 3583 shares of ProPhase Labs at 3.14 subject to Rule 16... at MacroaxisInsider
24th of January 2025
ProPhase Labs Now Covered by Analysts at StockNews.com at thelincolnianonline.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ProPhase Labs in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ProPhase Labs' short interest history, or implied volatility extrapolated from ProPhase Labs options trading.
Check out ProPhase Labs Backtesting and ProPhase Labs Hype Analysis. For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProPhase Labs. If investors know ProPhase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProPhase Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share (1.53) | Revenue Per Share | Quarterly Revenue Growth (0.62) | Return On Assets |
The market value of ProPhase Labs is measured differently than its book value, which is the value of ProPhase that is recorded on the company's balance sheet. Investors also form their own opinion of ProPhase Labs' value that differs from its market value or its book value, called intrinsic value, which is ProPhase Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProPhase Labs' market value can be influenced by many factors that don't directly affect ProPhase Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProPhase Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProPhase Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProPhase Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.